Indivior suffers a major downfall due to its loss in the patent case

PUBLISHED BY
Carrie Ann



TAGS:


4 years ago




There are two factors in life the leniency of which can cause major physical as well as mental issues.  One is getting the right diagnosis by the doctor and the other is an intake of the right medicines. If any of these go wrong, you may have to strive hard to survive. But if they are done right, then it can lead you to a healthier life. After all, if you don’t have a healthy life than money and success are unimportant. This is why any kind of negative publicity can adversely affect the progress rate of any pharmaceutical company. This is what happened with Indivior as well.

Indivior is a pharmaceutical company based in London which was founded in the year of 1994. The company mainly specializes in producing medicines that can help you get rid of an addiction. This is very tricky business as a consumer may get the hang of using these medicines as an alternative to addiction. This is why pharmaceutical manufacturers have to be precise with their chemical formulas. Owing to this kind of importance, Indivior was proud of its expertise. Turns out that its field of expertise wasn’t unique after all. This knowledge came to the light after a recent ruling by the U.S. court. Also, it led to the decline of the company in terms of its share prices.

Indivior

Indivior is a pharmaceutical company based in London which was founded in the year of 1994.

More about Indivior’s patent case

Friday morning witness the drop of Indivior’s stock prices by almost 40 percent. This sudden downfall took place as a result of the U.S. court ruling not turning out in the company’s favor. The company had challenged its rivals in the U.S. court that they had infringed upon its patent of a particular drug. The company majorly attains its income through Suboxone, which is a heroin addiction treatment. As it generates most of its finance from the sale of this drug, it wanted to make sure that no other company sold the same. But its plan significantly backfired.

As Indivior lost the case, its competitive rivals can legally produce a drug similar to Suboxone. This can cause tremendous loss to the company as Suboxone has 61 percent of market share in the U.S. itself. The sale of this drug adds up to 80 percent of the company’s revenue. CEO of Indivior, Shaun Thaxter stated that the company is extremely disappointed with the legal ruling. There is no definite idea about the loss it will cause but its adverse effects are already visible.

Carrie Ann
Carrie Ann is Editor-in-Chief at Industry Leaders Magazine, based in Las Vegas. Carrie covers technology, trends, marketing, brands, productivity, and leadership. When she isn’t writing she prefers reading. She loves reading books and articles on business, economics, corporate law, luxury products, artificial intelligence, and latest technology. She’s keen on political discussions and shares an undying passion for gadgets. Follow Carrie Ann on Twitter, Facebook

Recent Posts

Why Is Squid Game So Popular?

Why Is Squid Game So Popular?

The Squid Game segments were watched by at least 132 million people in the first 23 days of the show on Netflix. Know what excited the viewers.
11 hours ago
Amazon under Congressional scrutiny for pushing own products over others

Amazon under Congressional scrutiny for pushing own products over others

US judiciary Antitrust Committee writes a letter saying that Amazon is given time till November 1 to prove that it utilizes seller data available to create competing products and p
1 day ago
Porsche’s Taycan EV outsells ICE powered its 911 sports car

Porsche’s Taycan EV outsells ICE powered its 911 sports car

The Porsche Taycan EV has outsold the Porsche 911 sports car for the first time since it was introduced in 2019 by the German automaker.
2 days ago
Tesla expected to make a killing in Bitcoin profits in next earning report

Tesla expected to make a killing in Bitcoin profits in next earning report

The price of Bitcoins has rallied to another high in October after hitting around $64,800 in April. This time it has hit over $58,000 on Oct. 14.
3 days ago
Tesla Cybertruck V/s Rivian’s R1T

Tesla Cybertruck V/s Rivian’s R1T

The Tesla Cyberturck left many disappointed with its alien space ship-like design; though both trucks are still under production, what matters most is what comes under the hood.
5 days ago
College sports is multibillion dollar industry in the US

College sports is multibillion dollar industry in the US

According to data analyzed by GOBankingRates, head football coaches, closely followed by basketball coaches, easily rack up seven-figure salaries in the US.
6 days ago